Experts to discuss the benefits of glucagon/GLP-1 receptor dual agonism gleaned from SYNCHRONIZE Lee Kaplan, MD, PhD, and other investigators will examine the basic science underlying injectable survodutide, as well as results from two of the four studies in the SYNCHRONIZE program
Its important to start slowly and gradually increase the intensity of your workouts to avoid injury and allow your body to adjust
It works by signaling your pancreas to release insulin after meals, slowing digestion, and helping you feel fuller longerultimately controlling appetite and blood sugar more effectively
Knowing this connection helps you better prepare for and manage this side effect during your treatment journey
Retatrutides approach of adding glucagon activation to established GLP-1 and GIP effects opens metabolic possibilities that werent available even three years ago
A dedicated single-injection 7.2 mg pen is expected later in 2026